Sign in

    Ben...

    Senior Equity Research Analyst at Stephens Inc.

    Ben is a Senior Equity Research Analyst at Stephens Inc., specializing in coverage of regional banks and financial institutions. He closely follows companies such as Hancock Whitney Corporation, providing in-depth analysis and investment recommendations that have contributed to positive returns and recognition by investors. Ben joined Stephens Inc. after accumulating several years of experience in financial analysis, having previously held roles at other major firms within the banking sector. He holds FINRA registration and maintains securities licenses that validate his expertise in equity research and financial markets.

    Ben...'s questions to ABBNY leadership

    Ben...'s questions to ABBNY leadership • Q1 2025

    Question

    Ben, via the online portal, asked for clarification on the portfolio change, specifically whether the Machine Automation business will become a separate division within Process Automation.

    Answer

    CEO Morten Wierod confirmed that Machine Automation will be moved into Process Automation as a separate division. He noted its performance is improving and it will continue to collaborate on projects across ABB, contributing its PLC and automation solutions where relevant, such as in the energy and infrastructure industries.

    Ask Fintool Equity Research AI

    Ben...'s questions to MYRIAD GENETICS (MYGN) leadership

    Ben...'s questions to MYRIAD GENETICS (MYGN) leadership • Q4 2024

    Question

    Ben..., on behalf of Jason Deuchler, asked for commentary on the market reception of the Prequel launch at 8 weeks and sought confirmation of guidance for double-digit hereditary cancer testing volume growth in 2025.

    Answer

    CEO Paul Diaz reported that while it's still early, there has been significant excitement from providers for the 8-week Prequel launch because it aligns with the first patient visit and improves clinical workflows. He then clarified that the company does not provide guidance for specific product volumes, though management has previously discussed expectations for stable overall ASPs.

    Ask Fintool Equity Research AI